1-7 of 7
Sheng-Chieh Chou
Close
Sort by
Journal Articles

Safety of Crovalimab Versus Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Pooled Results from the Phase III COMMODORE 1, COMMODORE 2, and COMMODORE 3 Studies

Alexander Roeth, Rong FU, Guangsheng He, Hazza A Alzahrani, Sheng-Chieh Chou, Yosr Hicheri, Maciej Kazmierczak, Viviane Lacorte Recova, Michihiro Uchiyama, ANA Maria Vladareanu, Leigh Beveridge, Simon Buatois, Muriel Buri, Dayu Shi, Nadiesh Balachandran, Sasha Srekovic, Phillip Scheinberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 575.
https://doi.org/10.1182/blood-2023-177618
Published: 2023
Journal Articles

Bone Health of Hemophilia Ａ Patients Using Emicizumab

Ting-Wei Lyu, Ting Sun, Sheng-Chieh Chou
Journal: Blood
Blood (2023) 142 (Supplement 1): 2620.
https://doi.org/10.1182/blood-2023-174200
Published: 2023
Journal Articles

Relationship between Endogenous, Transgene FVIII Expression and Bleeding Events Following Valoctocogene Roxaparvovec Gene Transfer for Severe Hemophilia A: A Post-Hoc Analysis of the GENEr8-1 Phase 3 Trial

Steven W Pipe, Margareth C Ozelo, Gili Kenet, Mark T Reding, Jane Mason, Andrew D Leavitt, Bella Madan, Michael Laffan, Doris V. Quon, Annette von Drygalski, Sheng-Chieh Chou, Susan Shapiro, Amy L Dunn, Michael Wang, Nigel S Key, Radoslaw Kaczmarek, Emily Symington, Adebayo Lawal, Reena Mahajan, Konstantia-Maria Chavele, Divya B Reddy, Hua Yu, Wing Yen Wong, Tara M Robinson, Benjamin Kim
Journal: Blood
Blood (2021) 138 (Supplement 1): 3972.
https://doi.org/10.1182/blood-2021-144508
Published: 2021
Journal Articles

Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3 -ITD Patients

Sheng-Chuan Huang, MD, Hsin-An Hou, MD PhD, Cheng-Hong Tsai, MD, M.Sc., Wen-Chien Chou, MD, PhD, Jih-Luh Tang, MD, Ming Yao, MD, Bor-Sheng Ko, MD PhD, Feng-Ming Tien, Yuan-Yeh Kuo, PhD, Mei-Hsuan Tseng, M.Sc., Chien-Chin Lin, MD, Chien-Ting Lin, MD, Ming-Kai Chuang, MD, Tai-Chung Huang, MD PhD, Chien-Yuan Chen, MD, PhD, Szu-Chun Hsu, MD, Chieh-Lung Cheng, MD, Huai-Hsuan Huang, MD, Sheng-Chieh Chou, MD, Shang-Ju Wu, MD, PhD, Shang-YI Huang, Hwei-Fang Tien, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3977.
https://doi.org/10.1182/blood-2018-99-114315
Published: 2018
Journal Articles

Retrospective Analysis of Cancer-Associated Venous Thromboembolism in Patients with High Risk Cancer Types in Taiwan

Sheng-Chieh Chou, MD, Woei Tsai, MD, PhD, Shu-Wha Lin, PhD, Hwei-Fang Tien, MD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3699.
https://doi.org/10.1182/blood.V130.Suppl_1.3699.3699
Published: 2017
Journal Articles

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

Clinical Trials & Observations
Wen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, Chien-Yuan Chen, Hsin-An Hou, Yuan-Yeh Kuo, Ming-Cheng Lee, Bor-Sheng Ko, Jih-Luh Tang, Ming Yao, Woei Tsay, Shang-Ju Wu, Shang-Yi Huang, Szu-Chun Hsu, Yao-Chang Chen, Yi-Chang Chang, Yi-Yi Kuo, Kuan-Ting Kuo, Fen-Yu Lee, Ming-Chi Liu, Chia-Wen Liu, Mei-Hsuan Tseng, Chi-Fei Huang, Hwei-Fang Tien
Journal: Blood
Blood (2011) 118 (14): 3803–3810.
https://doi.org/10.1182/blood-2011-02-339747
Published: 2011
Includes: Supplemental data
Journal Articles

Role of Gene Mutations in Adult Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

Sheng-Chieh Chou, Jih-Luh Tang, MD, PhD, Liang-In Lin, PhD, Hsin-An Hou, Chien-Yuan Chen, Szu-Chun Hsu, Bo-Sheng Ko, Shang-Yi Huang, MD, Wen-Chien Chou, Ming Yao, Woei Tsay, Yao-Chang Chen, Hwei-Fang Tien
Journal: Blood
Blood (2009) 114 (22): 3373.
https://doi.org/10.1182/blood.V114.22.3373.3373
Published: 2009